Exercise and 6R-BH4 for Chronic Kidney Disease

Neurovascular Transduction During Exercise in Chronic Kidney Disease

Recruiting Phase 2 Interventional Study
Renal Insufficiency, Chronic
Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 75
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Supportive Care
Participants needed
150 (estimated)
Sponsor
Emory University · Other
Who this trial is looking for

This trial is looking for people with chronic kidney disease who want to understand their exercise difficulties and high blood pressure during exercise. Participants will try regular cycling exercise and take a pill to see if it helps improve their exercise capacity.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have chronic kidney disease stage III or IV.
  • I do not exercise regularly.
  • I am stable with my kidney function and my levels have not dropped by more than 30% in the last 3 months.
  • I am willing to follow the study rules.

You may not be able to join if

  • I have severe chronic kidney disease.
  • I abuse drugs or alcohol.
  • I have diabetic neuropathy.
  • I have serious health problems affecting my survival.
  • I have severe anemia.
  • I have heart failure or a serious heart condition.
  • I have uncontrolled high blood pressure.
  • I am pregnant or planning to become pregnant.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The purpose of this study is to find out why patients with chronic kidney disease (CKD) have poor exercise capacity and to explore what causes an increase in blood pressure during exercise (i.e. increased adrenaline levels, or decreased ability of blood vessels to dilate). This study will also test whether or not regular exercise on a bicycle and/or treatment with 6R-BH4 (Kuvan) pills, or histidin…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria for Chronic Kidney Disease Patients: * Stage III or IV Chronic Kidney Disease, defined as reduction in estimated glomerular filtration rate (eGFR) to 15-59 cc/minute as calculated by the modified Modification of Diet in Renal Disease (MDRD) Study equation or the Chronic Kidney Di…
Contacts

Jeanie Park, MD

404-727-2525

jeanie.park@emory.edu

CONTACT